RAPT Therapeutics, Inc.
RAPT
$31.90
-$0.43-1.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 157.34M | 168.95M | 179.28M | 231.06M | 97.91M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.70M | 3.91M | 3.92M | 4.18M | 4.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 161.05M | 172.86M | 183.20M | 235.24M | 102.60M |
|
|
|||||
| Total Current Assets | 161.05M | 172.86M | 183.20M | 235.24M | 102.60M |
| Net Property, Plant & Equipment | 2.65M | 3.28M | 3.99M | 4.70M | 5.48M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.05M | 2.27M | 389.00K | 389.00K | 389.00K |
| Total Assets | 165.74M | 178.41M | 187.57M | 240.33M | 108.47M |
|
|
|||||
| Total Accounts Payable | 2.10M | 4.19M | 1.30M | 1.28M | 1.38M |
| Total Accrued Expenses | 9.01M | 6.58M | 4.93M | 44.60M | 6.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.21M | 2.21M | 2.32M | 2.42M | 2.52M |
| Total Finance Division Other Current Liabilities | 56.00K | 66.00K | 140.00K | 57.00K | 61.00K |
| Total Other Current Liabilities | 56.00K | 66.00K | 140.00K | 57.00K | 61.00K |
| Total Current Liabilities | 13.38M | 13.04M | 8.68M | 48.35M | 10.36M |
|
|
|||||
| Total Current Liabilities | 13.38M | 13.04M | 8.68M | 48.35M | 10.36M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 387.00K | 959.00K | 1.52M | 2.07M | 2.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.76M | 14.00M | 10.20M | 50.42M | 12.96M |
|
|
|||||
| Common Stock & APIC | 818.81M | 813.75M | 809.05M | 804.40M | 656.70M |
| Retained Earnings | -666.94M | -649.36M | -631.71M | -614.55M | -561.30M |
| Treasury Stock & Other | 100.00K | 16.00K | 35.00K | 50.00K | 107.00K |
| Total Common Equity | 151.98M | 164.41M | 177.37M | 189.90M | 95.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 151.98M | 164.41M | 177.37M | 189.90M | 95.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 151.98M | 164.41M | 177.37M | 189.90M | 95.51M |
|
|
|||||